GDRX - NASDAQ

GoodRx Holdings, Inc.

GDRX·NASDAQ

$2.81

-4.7%

HealthcareMedical - Healthcare Information Services

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$974.03M

EPS0.0854

P/E Ratio32.90

Earnings Date08/05/2026

1.40B

Assets

3Y-12.0%

5Y-6.0%

10Y+375.0%

787.80M

Total Liabilities

19%

3Y-

5Y+1.0%

10Y+1610.0%

616.26M

Total Equity

-15%

3Y-24.0%

5Y-13.0%

10Y+7500.0%

GoodRx Holdings, Inc. Funding & Solvency Profile

GDRX · NASDAQ

Current Assets

Cash & Cash Equivalents261.82M

Net Receivables235.75M

Inventory0.00

Other Current Assets145.54M

Total Current Assets643 M

Non-Current Assets

Property, Plant & Equipment41.08M

Goodwill & Intangible Assets494.41M

Long-Term Investments0.00

Other Non-Current Assets168.36M

Total Non-Current Assets209 M

Total Assets

1.40B

Financial Health Analysis

Current Ratio

2.61x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.28x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

397 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

46% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

GoodRx Holdings, Inc. Balance Sheet

GDRX • NASDAQ

GoodRx Holdings, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	261.8M	448.3M	672.3M	757.2M	941.1M	971.6M	26.1M	34.6M	17.5M	23.6M
Cash & Short-Term Investments	261.8M	448.3M	672.3M	757.2M	941.1M	971.6M	26.1M	34.6M	17.5M	23.6M
Net Receivables	235.7M	160.8M	160M	121.7M	126.4M	97.3M	55.5M	33.4M	0.0	0.0
Accounts Receivables	235.7M	145.9M	143.6M	117.1M	118.1M	68.7M	48.1M	33.4M	0.0	0.0
Other Receivables	0.0	14.9M	16.4M	4.5M	8.3M	28.6M	7.4M	0.0	0.0	0.0
Prepaids	0.0	0.0	25M	5.8M	0.0	17.5M	5M	3.4M	0.0	0.0
Other Current Assets	145.5M	50.1M	15.5M	35.1M	21.3M	0.0	0.0	1.7M	-17.5M	-23.6M
Total Current Assets	643.1M	659.3M	872.8M	919.7M	1.1B	1.1B	86.6M	73.1M	0.0	0.0
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	41.1M	40.5M	45.9M	55.7M	49.3M	50.8M	34.2M	988K	0.0	0.0
Goodwill	430.3M	410.8M	410.8M	412.1M	329.7M	261.1M	236.2M	220.4M	0.0	0.0
Intangible Assets	64.1M	176.9M	156.3M	189.9M	133.8M	56.7M	26.4M	18.3M	0.0	0.0
Goodwill & Intangible Assets	494.4M	587.7M	567.1M	602.1M	463.5M	317.8M	262.7M	238.7M	0.0	0.0
Long-Term Investments	0.0	15M	15M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	57.1M	77.2M	65.3M	0.0	0.0	37.6M	2.2M	866K	0.0	0.0
Other Non-Current Assets	168.4M	8.5M	22.8M	27.2M	6M	2M	1.2M	1.2M	0.0	0.0
Total Non-Current Assets	761M	728.8M	716M	684.9M	518.8M	408.2M	300.2M	241.7M	286.9M	295.6M
Total Assets	1.4B	1.4B	1.6B	1.6B	1.6B	1.5B	386.8M	314.8M	286.9M	295.6M
LIABILITIES
CURRENT LIABILITIES
Total Payables	19.4M	15.6M	36.3M	17.7M	17.5M	10.3M	9.2M	7.2M	0.0	0.0
Accounts Payable	19.4M	14.1M	36.3M	17.7M	17.5M	10.3M	7.9M	7.2M	0.0	0.0
Other Payables	0.0	1.5M	0.0	0.0	0.0	0.0	1.3M	0.0	0.0	0.0
Accrued Expenses	0.0	28.3M	30.4M	39.6M	43.9M	13.6M	10.8M	1.2M	0.0	0.0
Short Term Debt	9.8M	5M	8.8M	7M	7M	11.6M	7M	5.4M	0.0	0.0
Capital Lease Obligations (Current)	0.0	5.6M	6.2M	4.1M	5.9M	0.0	2.9M	0.0	0.0	0.0
Tax Payables	0.0	1.5M	0.0	0.0	0.0	0.0	1.3M	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	7.1M	7.9M	6.9M	6.9M	3.5M	258K	0.0	0.0
Other Current Liabilities	216.8M	69.4M	33.8M	0.0	0.0	17.2M	0.0	2.5M	0.0	0.0
Total Current Liabilities	246M	123.9M	122.6M	76.3M	81.1M	59.6M	33.4M	16.6M	0.0	0.0
NON-CURRENT LIABILITIES
Long Term Debt	49.8M	486.7M	647.7M	651.8M	655.9M	659.9M	663.9M	716.8M	136M	46.1M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	737M	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	244K	24.5M	0.0	3.5M	0.0	0.0
Other Non-Current Liabilities	492M	6.8M	8.2M	7.6M	5.1M	5.8M	740M	-733.7M	0.0	0.0
Total Non-Current Liabilities	541.8M	539.5M	704.3M	713.5M	694.8M	723.7M	1.4B	1.5B	136M	46.1M
Capital Lease Obligations	0.0	51.7M	54.6M	58.2M	39.4M	33.5M	40.1M	0.0	0.0	0.0
Total Liabilities	787.8M	663.4M	826.8M	789.8M	775.9M	783.2M	1.5B	1.5B	136M	46.1M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	737M	166.8M	166.8M
Common Stock	34K	38K	40K	40K	40K	39K	460K	451K	0.0	0.0
Additional Paid-In Capital	0.0	2.2B	2.2B	2.3B	2.2B	2.1B	8.8M	0.0	0.0	0.0
Retained Earnings	-1.4B	-1.4B	-1.5B	-1.4B	-1.4B	-1.4B	-1.1B	-1.2B	-86.2M	8.1M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-554K	0.0	0.0
Other Total Stockholders' Equity	2B	0.0	0.0	0.0	0.0	0.0	0.0	554K	-166.8M	-166.8M
Total Stockholders' Equity	616.3M	724.7M	762M	814.8M	831.7M	711.4M	-1.1B	-1.2B	-86.2M	8.1M
Total Equity	616.3M	724.7M	762M	814.8M	831.7M	711.4M	-1.1B	-1.2B	-86.2M	8.1M
SUMMARY
Total Liabilities & Equity	1.4B	1.4B	1.6B	1.6B	1.6B	1.5B	386.8M	314.8M	49.8M	54.2M
Total Investments	0.0	15M	15M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	59.5M	543.4M	711.1M	717M	702.3M	704.9M	711M	722.2M	136M	46.1M
Net Debt	-202.3M	95M	38.8M	-40.1M	-238.8M	-266.7M	684.9M	687.6M	118.5M	22.5M
Shares Outstanding	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014	339,433,014

SEC Filings

GDRX - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 06, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 06, 2026	May 06, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 29, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	April 24, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 03, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 27, 2026	March 24, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 06, 2026	March 03, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 26, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 106 filings

Related Guides

Blog Categories

Continue your GDRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.